United States Influenza Drugs Market Report 2017

October 2017 | 105 pages | ID: UA842F0A5FAEN
QYResearch

Abstracts

In this report, the United States Influenza Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Influenza Drugs in these regions, from 2012 to 2022 (forecast).

United States Influenza Drugs market competition by top manufacturers/players, with Influenza Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bristol-Myers Squibb]
• AstraZeneca
• Eli Lilly
• Roche
• GlaxoSmithKline
• Novartis
• Pfizer
• Sanofi Pasteur
• Bayer
• Celgene
• Seqirus
• Protein Sciences Corporation
• Serum Institute of India
• Emergent Biosolutions
• BioCryst Pharmaceuticals
• Alvogen

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Zanamivir
• Oseltamivir Phosphate
• Peramivir
• Other Influenza Drugs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Influenza Drugs for each application, including

• Adults
• Chidren

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Influenza Drugs Market Report 2017

1 INFLUENZA DRUGS OVERVIEW

1.1 Product Overview and Scope of Influenza Drugs
1.2 Classification of Influenza Drugs by Product Category
  1.2.1 United States Influenza Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Influenza Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Zanamivir
  1.2.4 Oseltamivir Phosphate
  1.2.5 Peramivir
  1.2.6 Other Influenza Drugs
1.3 United States Influenza Drugs Market by Application/End Users
  1.3.1 United States Influenza Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Adults
  1.3.3 Chidren
1.4 United States Influenza Drugs Market by Region
  1.4.1 United States Influenza Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Influenza Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Influenza Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Influenza Drugs Status and Prospect (2012-2022)
  1.4.5 New England Influenza Drugs Status and Prospect (2012-2022)
  1.4.6 The South Influenza Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Influenza Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Influenza Drugs (2012-2022)
  1.5.1 United States Influenza Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Influenza Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES INFLUENZA DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Influenza Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Influenza Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Influenza Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Influenza Drugs Market Competitive Situation and Trends
  2.4.1 United States Influenza Drugs Market Concentration Rate
  2.4.2 United States Influenza Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Influenza Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES INFLUENZA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Influenza Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Influenza Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Influenza Drugs Price by Region (2012-2017)

4 UNITED STATES INFLUENZA DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Influenza Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Influenza Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Influenza Drugs Price by Type (2012-2017)
4.4 United States Influenza Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES INFLUENZA DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Influenza Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Influenza Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES INFLUENZA DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bristol-Myers Squibb]
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Influenza Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.2 Influenza Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly
  6.3.2 Influenza Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Roche
  6.4.2 Influenza Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Roche Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline
  6.5.2 Influenza Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Influenza Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Influenza Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sanofi Pasteur
  6.8.2 Influenza Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bayer
  6.9.2 Influenza Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bayer Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Celgene
  6.10.2 Influenza Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Celgene Influenza Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Seqirus
6.12 Protein Sciences Corporation
6.13 Serum Institute of India
6.14 Emergent Biosolutions
6.15 BioCryst Pharmaceuticals
6.16 Alvogen

7 INFLUENZA DRUGS MANUFACTURING COST ANALYSIS

7.1 Influenza Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Influenza Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Influenza Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Influenza Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES INFLUENZA DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Influenza Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Influenza Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Influenza Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Influenza Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Influenza Drugs
Figure United States Influenza Drugs Market Size (K MT) by Type (2012-2022)
Figure United States Influenza Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Zanamivir Product Picture
Figure Oseltamivir Phosphate Product Picture
Figure Peramivir Product Picture
Figure Other Influenza Drugs Product Picture
Figure United States Influenza Drugs Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Influenza Drugs by Application in 2016
Figure Adults Examples
Table Key Downstream Customer in Adults
Figure Chidren Examples
Table Key Downstream Customer in Chidren
Figure United States Influenza Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Influenza Drugs Sales (K MT) and Growth Rate (2012-2022)
Figure United States Influenza Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Influenza Drugs Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Influenza Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Influenza Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Influenza Drugs Sales Share by Players/Suppliers
Figure 2017 United States Influenza Drugs Sales Share by Players/Suppliers
Figure United States Influenza Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Influenza Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Influenza Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Influenza Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Influenza Drugs Revenue Share by Players/Suppliers
Table United States Market Influenza Drugs Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Influenza Drugs Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Influenza Drugs Market Share of Top 3 Players/Suppliers
Figure United States Influenza Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Influenza Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Influenza Drugs Product Category
Table United States Influenza Drugs Sales (K MT) by Region (2012-2017)
Table United States Influenza Drugs Sales Share by Region (2012-2017)
Figure United States Influenza Drugs Sales Share by Region (2012-2017)
Figure United States Influenza Drugs Sales Market Share by Region in 2016
Table United States Influenza Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Influenza Drugs Revenue Share by Region (2012-2017)
Figure United States Influenza Drugs Revenue Market Share by Region (2012-2017)
Figure United States Influenza Drugs Revenue Market Share by Region in 2016
Table United States Influenza Drugs Price (USD/MT) by Region (2012-2017)
Table United States Influenza Drugs Sales (K MT) by Type (2012-2017)
Table United States Influenza Drugs Sales Share by Type (2012-2017)
Figure United States Influenza Drugs Sales Share by Type (2012-2017)
Figure United States Influenza Drugs Sales Market Share by Type in 2016
Table United States Influenza Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Influenza Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Influenza Drugs by Type (2012-2017)
Figure Revenue Market Share of Influenza Drugs by Type in 2016
Table United States Influenza Drugs Price (USD/MT) by Types (2012-2017)
Figure United States Influenza Drugs Sales Growth Rate by Type (2012-2017)
Table United States Influenza Drugs Sales (K MT) by Application (2012-2017)
Table United States Influenza Drugs Sales Market Share by Application (2012-2017)
Figure United States Influenza Drugs Sales Market Share by Application (2012-2017)
Figure United States Influenza Drugs Sales Market Share by Application in 2016
Table United States Influenza Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Influenza Drugs Sales Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb] Basic Information List
Table Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb] Influenza Drugs Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb] Influenza Drugs Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb] Influenza Drugs Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AstraZeneca Influenza Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Influenza Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Influenza Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly Influenza Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly Influenza Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly Influenza Drugs Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Influenza Drugs Sales Growth Rate (2012-2017)
Figure Roche Influenza Drugs Sales Market Share in United States (2012-2017)
Figure Roche Influenza Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Influenza Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Influenza Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Influenza Drugs Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Influenza Drugs Sales Growth Rate (2012-2017)
Figure Novartis Influenza Drugs Sales Market Share in United States (2012-2017)
Figure Novartis Influenza Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Influenza Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Influenza Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Influenza Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Influenza Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur Influenza Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur Influenza Drugs Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Influenza Drugs Sales Growth Rate (2012-2017)
Figure Bayer Influenza Drugs Sales Market Share in United States (2012-2017)
Figure Bayer Influenza Drugs Revenue Market Share in United States (2012-2017)
Table Celgene Basic Information List
Table Celgene Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celgene Influenza Drugs Sales Growth Rate (2012-2017)
Figure Celgene Influenza Drugs Sales Market Share in United States (2012-2017)
Figure Celgene Influenza Drugs Revenue Market Share in United States (2012-2017)
Table Seqirus Basic Information List
Table Protein Sciences Corporation Basic Information List
Table Serum Institute of India Basic Information List
Table Emergent Biosolutions Basic Information List
Table BioCryst Pharmaceuticals Basic Information List
Table Alvogen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Drugs
Figure Manufacturing Process Analysis of Influenza Drugs
Figure Influenza Drugs Industrial Chain Analysis
Table Raw Materials Sources of Influenza Drugs Major Players/Suppliers in 2016
Table Major Buyers of Influenza Drugs
Table Distributors/Traders List
Figure United States Influenza Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Influenza Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Influenza Drugs Price (USD/MT) Trend Forecast (2017-2022)
Table United States Influenza Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Influenza Drugs Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Influenza Drugs Sales Volume (K MT) Forecast by Type in 2022
Table United States Influenza Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Influenza Drugs Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Influenza Drugs Sales Volume (K MT) Forecast by Application in 2022
Table United States Influenza Drugs Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Influenza Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Influenza Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Influenza Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources